The p53-inducible apoptotic protein AMID is not required for normal development and tumor suppression

Oncogene

Volumn 25, Issue 6, 2006, Pages 849-856

  Mei, J ^a   Webb, S ^a   Zhang, B ^a   Shu, H B ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b WUHAN UNIVERSITY   (China)

Author keywords

AMID; Apoptosis; Knockout; p53; Tumor suppression

Indexed keywords

3 METHYLCHOLANTHRENE; APOPTOSIS INDUCING FACTOR HOMOLOGOUS AND MITOCHONDRIA ASSOCIATED PROTEIN; FLAVOPROTEIN; PROTEIN P53; TOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; EMBRYO; EMBRYO CELL; FEMALE; FERTILITY; FIBROBLAST; FIBROSARCOMA; GENE TARGETING; INOCULATION; MALE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, TUMOR SUPPRESSOR; MALE; MICE; MICE, MUTANT STRAINS; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENICITY TESTS; NEOPLASMS; REFERENCE VALUES; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 32544458675     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209121     Document Type: Article

References (28)

1. Amarante-Mendes GP, Finucane DM, Martin SJ, Cotter TG, Salvesen GS, Green DR. (1998). Cell Death Differ 5: 298-306.
2. Bidere N, Senik A. (2001). Apoptosis 6: 371-375.
3. Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N et al. (2002). Biochimie 84: 215-222.
4. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. (1998). Cell 94: 727-737.
5. Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N et al. (2000). FEBS Lett 476: 118-123.
6. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Nature 356: 215-221.
7. Du C, Fang M, Li Y, Li L, Wang X. (2000). Cell 102: 33-42.
8. Giaccia AJ, Kastan MB. (1998). Genes Dev 12: 2973-2983.
9. Green DR, Reed JC. (1998). Science 281: 1309-1312.
10. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS et al. (1998). Cell 94: 339-352.
11. Hansen R, Oren M. (1997). Curr Opin Genet Dev 7: 46-51.
12. Hengartner MO. (2000). Nature 407: 770-776.
13. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY et al. (2001). Nature 410: 549-554.
14. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H et al. (1996). Nature 384: 368-372.
15. Levine AJ. (1997). Cell 88: 323-331.
16. Li K, Li Y, Shelton JM, Richardson JA, Spencer E, Chen ZJ et al. (2000). Cell 101: 389-399.
17. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. (1996). Cell 86: 147-157.
18. Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G et al. (2001). J Biol Chem 276: 16391-16398.
19. Mosmann T. (1983). J Immunol Methods 65: 55-63.
20. Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT et al. (2002). FEBS Lett 524: 163-171.
21. Prives C, Hall PA. (1999). J Pathol 187: 112-126.
22. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM et al. (1999). Nature 397: 441-446.
23. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE et al. (2000). Cell 102: 43-53.
24. Wang X. (2001). Genes Dev 15: 2922-2933.
25. Wu M, Xu LG, Li X, Zhai Z, Shu HB. (2002). J Biol Chem 277: 25617-25623.
26. Wu M, Xu LG, Su T, Tian Y, Zhai Z, Shu HB. (2004). Oncogene 23: 6815-6819.
27. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R et al. (1998). Cell 94: 739-750.
28. Zhang P, Li MZ, Elledge SJ. (2002). Nat Genet 30: 31-39.